BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37108853)

  • 1. COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment-A Retrospective Study.
    Nuh A; Ramadan N; Nwankwo L; Donovan J; Patel B; Shah A; Desai SR; Armstrong-James D
    J Fungi (Basel); 2023 Mar; 9(4):. PubMed ID: 37108853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
    Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
    J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of
    Takazono T; Ito Y; Tashiro M; Nishimura K; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active screening of COVID-19-associated pulmonary aspergillosis with serum beta-glucan and endotracheal aspirates galactomannan and fungal culture.
    Pavone P; Russello G; Salati G; Corsini R; Salsi P; Vizzini L; Lombardini C; Spaggiari L; Besutti G; Menozzi V; Spadoni A; Facciolongo N; Piro R; Carretto E; Massari M
    Mycoses; 2023 Mar; 66(3):219-225. PubMed ID: 36380646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
    Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
    Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
    Dai Z; Cai M; Yao Y; Zhu J; Lin L; Fang L; Li Z; Yi H; Chen B; Liang X
    Medicine (Baltimore); 2021 Apr; 100(14):e25233. PubMed ID: 33832082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
    Zhou W; Li H; Zhang Y; Huang M; He Q; Li P; Zhang F; Shi Y; Su X
    J Clin Microbiol; 2017 Jul; 55(7):2153-2161. PubMed ID: 28446576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis.
    Sehgal IS; Dhooria S; Choudhary H; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30626661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
    Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
    BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis.
    He Q; Zhang M; Feng C
    BMC Pulm Med; 2021 Dec; 21(1):414. PubMed ID: 34915889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
    Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
    He H; Ding L; Sun B; Li F; Zhan Q
    Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of
    Ye F; Zeng P; Li Z; Tang C; Liu W; Su D; Zhan Y; Li S
    Ann Clin Lab Sci; 2021 Sep; 51(5):698-704. PubMed ID: 34686513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
    Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of detecting bronchoalveolar lavage fluid Aspergillus galactomannan antigen in the diagnosis of pulmonary aspergillosis].
    Hu H; Yang Y; Teng GL; Ju YF; Zhang LL; Wei M
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(32):2268-70. PubMed ID: 23158487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.